SynthesisAnnals of medicine2023

Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis.

Tirath Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.